{"id":"https://openalex.org/W3161908308","doi":"https://doi.org/10.1182/blood.v112.11.4199.4199","title":"Pim Kinase Inhibitor, SGI-1776, Induces Apoptosis in CLL Lymphocytes","display_name":"Pim Kinase Inhibitor, SGI-1776, Induces Apoptosis in CLL Lymphocytes","publication_year":2008,"publication_date":"2008-11-16","ids":{"openalex":"https://openalex.org/W3161908308","doi":"https://doi.org/10.1182/blood.v112.11.4199.4199","mag":"3161908308"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v112.11.4199.4199","doi":"https://doi.org/10.1182/blood.v112.11.4199.4199","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v112.11.4199.4199","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016660083","display_name":"Lisa S. Chen","orcid":"https://orcid.org/0000-0001-8020-3438","observed_orcids":["https://orcid.org/0000-0001-8020-3438"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lisa S Chen","raw_affiliation_strings":["Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089428686","display_name":"William G. Wierda","orcid":"https://orcid.org/0000-0002-7357-270X","observed_orcids":["https://orcid.org/0000-0002-7357-270X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William G Wierda","raw_affiliation_strings":["Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020548821","display_name":"Sanjeev Redkar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210149223","display_name":"SuperGen (United States)","ror":"https://ror.org/049922318","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210149223","https://openalex.org/I4387155454"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sanjeev Redkar","raw_affiliation_strings":["SuperGen Inc., Dublin, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SuperGen Inc., Dublin, CA, USA","institution_ids":["https://openalex.org/I4210149223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037979147","display_name":"David J. Bearss","orcid":"https://orcid.org/0000-0003-4940-9942","observed_orcids":["https://orcid.org/0000-0003-4940-9942"]},"institutions":[{"id":"https://openalex.org/I4210149223","display_name":"SuperGen (United States)","ror":"https://ror.org/049922318","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210149223","https://openalex.org/I4387155454"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David J. Bearss","raw_affiliation_strings":["SuperGen, Inc., Dublin, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SuperGen, Inc., Dublin, CA, USA","institution_ids":["https://openalex.org/I4210149223"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024454882","display_name":"Varsha V. Gandhi","orcid":"https://orcid.org/0000-0002-3172-9166","observed_orcids":["https://orcid.org/0000-0002-3172-9166"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Varsha Gandhi","raw_affiliation_strings":["Experimental Therapeutics and Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics and Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.306,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.66783442,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"112","issue":"11","first_page":"4199","last_page":"4199"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sgi-1776","display_name":"SGI-1776","score":0.8949999809265137},{"id":"https://openalex.org/keywords/pim-kinase-inhibitors","display_name":"PIM kinase inhibitors","score":0.7860000133514404},{"id":"https://openalex.org/keywords/pim-1","display_name":"PIM-1","score":0.8519999980926514},{"id":"https://openalex.org/keywords/pim2","display_name":"PIM2","score":0.9660000205039978},{"id":"https://openalex.org/keywords/pim3","display_name":"PIM3","score":0.9959999918937683},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9940000176429749},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8920000195503235},{"id":"https://openalex.org/keywords/kinase-inhibitor-selectivity","display_name":"kinase selectivity","score":0.8159999847412109},{"id":"https://openalex.org/keywords/primary-cll-cells","display_name":"primary CLL cells","score":0.5580000281333923},{"id":"https://openalex.org/keywords/zap-70","display_name":"ZAP-70","score":0.6859999895095825},{"id":"https://openalex.org/keywords/beta2-microglobulin","display_name":"beta2-microglobulin","score":0.8259999752044678},{"id":"https://openalex.org/keywords/igvh-mutation","display_name":"IgVH mutation","score":0.7210000157356262},{"id":"https://openalex.org/keywords/rai-stage","display_name":"Rai stage","score":0.7020000219345093},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6159999966621399},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.4569999873638153}],"concepts":[{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.8066477179527283},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5445681810379028},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.4897944927215576},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.4700823128223419},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.419761061668396},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.38565436005592346},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3713069260120392},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3017400801181793},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.21607354283332825},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.21193736791610718},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.20923131704330444}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v112.11.4199.4199","doi":"https://doi.org/10.1182/blood.v112.11.4199.4199","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v112.11.4199.4199","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.6499999761581421,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2103935957","https://openalex.org/W2036161687","https://openalex.org/W2130197839","https://openalex.org/W171696381","https://openalex.org/W4250771017","https://openalex.org/W2329820320","https://openalex.org/W7098958838","https://openalex.org/W2065564680","https://openalex.org/W2611746606","https://openalex.org/W2033508182"],"abstract_inverted_index":{"Abstract":[0],"We":[1,337],"report":[2],"investigational":[3],"studies":[4],"of":[5,18,30,35,74,138,197,224,246,272,287,294,300,307,343,371,395,422,447,463,470,475],"a":[6,12,136,362,375,386],"Pim-1":[7,61,87,179,309],"kinase":[8,28,168,304,310],"inhibitor,":[9],"SGI-1776,":[10,359],"as":[11,177],"therapeutic":[13],"agent":[14],"for":[15,96,122,151,215,236],"the":[16,75,119,128,173,213,269,298,340,420],"treatment":[17,323,353],"chronic":[19],"lymphocytic":[20],"leukemia":[21],"(CLL).":[22],"Pim":[23,36,50,152,303],"family":[24],"proteins":[25,442],"are":[26,481],"serine/threonine":[27],"inhibitors":[29],"apoptosis,":[31],"and":[32,44,59,71,83,88,112,125,144,166,170,185,201,232,249,264,285,314,390,473,477],"elevated":[33],"expression":[34,73,270],"kinases":[37,51,139,153,165],"have":[38,52,90,116,397],"been":[39,53,63,91],"detected":[40],"in":[41,45,69,81,118,240,244,260,268,324,327,335,364,388,403,419,431,440,457],"hematological":[42],"malignancies":[43],"certain":[46],"solid":[47],"tumors.":[48],"Three":[49],"identified":[54],"to":[55,65,93,115,147,217,368,409],"date,":[56],"Pim-1,":[57,123],"-2":[58],"-3.":[60],"has":[62],"shown":[64,92],"synergize":[66],"with":[67,209,229,253,354,483],"c-Myc":[68,344,391,478],"tumorigenesis,":[70],"increased":[72],"human":[76],"Pim-2":[77,89,182],"gene":[78],"is":[79,465],"observed":[80,259],"CLL":[82,226,274,458],"non-Hodgkin":[84],"lymphomas.":[85],"Specifically,":[86,172],"be":[94,148],"required":[95],"efficient":[97],"pre\u2013B-cell":[98],"transformation":[99],"by":[100,321,347,413],"v-Abl":[101],"oncogene.":[102],"Small":[103],"molecule":[104],"SGI-1776":[105,132,198,216,235,301,322,453],"was":[106,113,133,145,258,266,361,384,406,427,437],"evaluated":[107,212,297,339],"using":[108,127,374],"Ambit":[109],"Biosciences\u2019":[110],"KINOMEscan":[111],"found":[114,146],"IC50s":[117],"nanomolar":[120],"range":[121],"Pim-2,":[124],"Pim-3":[126,186],"Millipore":[129],"IC50":[130,174],"Profiler.":[131],"screened":[134],"against":[135],"panel":[137],"utilizing":[140],"radiolabeled":[141],"biochemical":[142],"assays,":[143],"highly":[149],"selective":[150],"without":[154],"any":[155],"effects":[156],"on":[157,302],"CDKs,":[158],"Chk1,":[159],"IKK,":[160],"JNK,":[161],"Abl,":[162],"Raf,":[163],"MAP":[164],"protein":[167,392,405,479],"A":[169],"B.":[171],"were":[175,199,318],"measured":[176,373],"follows:":[178],"(7":[180],"nM),":[181],"(363":[183],"nM)":[184],"(69":[187],"nM.)":[188],"The":[189,401],"other":[190],"two":[191],"enzymes":[192],"affected":[193,320],"at":[194],"nM":[195],"concentration":[196],"Flt-2":[200],"haspin.":[202],"Using":[203],"primary":[204,225],"samples":[205],"obtained":[206],"from":[207],"patients":[208],"CLL,":[210,325],"we":[211,296],"potential":[214,341],"induce":[218],"cell":[219,329],"death.":[220],"In":[221,434],"vitro":[222],"incubation":[223],"cells":[227],"(n=7),":[228],"1,":[230],"3,":[231],"10":[233,357],"\u03bcM":[234,358],"24":[237],"h":[238],"resulted":[239],"an":[241,332,429],"average":[242],"increase":[243,430],"apoptosis":[245,257,410,456],"10%,":[247],"22%":[248],"38%":[250],"respectively,":[251],"compared":[252],"untreated":[254],"cells.":[255,459],"SGI-1776-induced":[256,484],"heterogeneous":[261],"patient":[262],"populations,":[263],"there":[265,360,428,436],"disparity":[267],"levels":[271,480],"traditional":[273,308],"prognostic":[275],"markers":[276],"including":[277],"ZAP-70,":[278],"b2-microglobulin,":[279],"IgVH":[280],"mutation":[281],"status,":[282],"Rai":[283],"stage":[284],"number":[286],"prior":[288],"treatments.":[289],"To":[290],"elucidate":[291],"its":[292,461],"mechanism":[293,334,462],"action,":[295],"effect":[299],"function.":[305],"Phosphorylation":[306],"targets,":[311],"phospho-Bad":[312],"(Ser112)":[313],"histone":[315],"H3":[316],"(Ser10)":[317],"not":[319,407,466],"unlike":[326],"replicating":[328],"types,":[330],"suggesting":[331],"alternative":[333],"CLL.":[336],"then":[338],"inhibition":[342,469],"driven":[345],"transcription":[346],"measuring":[348],"total":[349,365],"RNA":[350,366,471],"synthesis.":[351],"Following":[352],"3":[355],"or":[356,411,449],"decrease":[363],"synthesis":[367,472],"approximately":[369],"50%":[370],"control,":[372],"radioactive":[376],"uridine":[377],"incorporation":[378],"assay":[379],"(n":[380],"=":[381],"3).":[382],"There":[383],"also":[385],"reduction":[387,402,417,474],"Mcl-1":[389,404,416,476],"level,":[393],"both":[394],"which":[396],"short":[398],"transcript":[399],"half-lives.":[400],"due":[408],"cleavage":[412],"caspases,":[414],"since":[415],"occurred":[418],"presence":[421],"caspase":[423],"inhibitor":[424],"ZVAD,":[425],"nor":[426],"cleaved":[432],"Mcl-1.":[433],"contrast,":[435],"no":[438],"change":[439],"anti-apoptotic":[441],"Bcl-2,":[443],"XIAP,":[444],"survivin,":[445],"stabilization":[446],"p53":[448],"p21.":[450],"Taken":[451],"together,":[452],"consistently":[454],"induced":[455],"Although":[460],"action":[464],"fully":[467],"elucidated,":[468],"associated":[482],"apoptosis.":[485]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2}],"updated_date":"2026-10-22T18:32:59.640997","created_date":"2021-05-24T00:00:00"}